HCRTR2 | Hypocretin (orexin) receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HTT | Huntingtin | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ITPR3 | Inositol 1,4,5-trisphosphate receptor, type 3 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KISS1R | KISS1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
LPHN2 | Latrophilin 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| | | | | Mixed |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MPDU1 | Mannose-P-dolichol utilization defect 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MRGPRF | MAS-related GPR, member F | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
MT-CO3 | Mitochondrially encoded cytochrome c oxidase III | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NMBR | Neuromedin B receptor | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NTSR1 | Neurotensin receptor 1 (high affinity) | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PARL | Presenilin associated, rhomboid-like | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PHTF1 | Putative homeodomain transcription factor 1 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PSEN2 | Presenilin 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PTAFR | Platelet-activating factor receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
PTCHD3 | Patched domain containing 3 | Predicted membrane proteins
| | | | | Tissue enriched |
RABGAP1 | RAB GTPase activating protein 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
RYR1 | Ryanodine receptor 1 (skeletal) | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A1 | Solute carrier family 16 (monocarboxylate transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC26A11 | Solute carrier family 26 (anion exchanger), member 11 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC30A7 | Solute carrier family 30 (zinc transporter), member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC35A2 | Solute carrier family 35 (UDP-galactose transporter), member A2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC37A3 | Solute carrier family 37, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC38A7 | Solute carrier family 38, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC4A1 | Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) | Blood group antigen proteins CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC50A1 | Solute carrier family 50 (sugar efflux transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC7A8 | Solute carrier family 7 (amino acid transporter light chain, L system), member 8 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLCO6A1 | Solute carrier organic anion transporter family, member 6A1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SSTR2 | Somatostatin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SSTR5 | Somatostatin receptor 5 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM115 | Transmembrane protein 115 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TMEM164 | Transmembrane protein 164 | Predicted membrane proteins
| | | | | Expressed in all |